|
US4210649A
|
|
Process for the treatment of patients suffering from drepanocytosis
|
|
CA1042438A
|
|
Process for the preparation of new pyridine derivatives
|
|
NL7706097A
|
|
Process for preparing pharmaceutical preparations and process for preparing medicinal compounds suitable for use in this process
|
|
DE2659104A1
|
|
MEDICINAL PRODUCTS FOR PROPHYLAXIS AND THERAPY BY BLOOD-SLUDGE
|
|
ZA7607652B
|
|
Process for the treatment of patients suffering from disorders induced by sludging
|
|
US4075215A
|
|
Thieno-pyridine derivatives
|
|
IL50020A
|
|
5-substituted-4,5,6,7-tetrahydro-thieno(3,2-c)pyridine derivatives and pharmaceutical compositions containing them
|
|
GR60364B7
|
|
Preparation process of thienopyridine derivatives
|
|
YU137876A
|
|
Process for obtaining new pyridine derivatives
|
|
US4080447A
|
|
Therapeutic composition having an inhibiting activity on blood plate aggregation
|
|
US4042590A
|
|
Diaminopropanols
|
|
DE2505502A1
|
|
CAGE FOR ANIMAL RISK IN LABORATORIES
|
|
US4018786A
|
|
2-Aminothiazolines and a process for preparation thereof
|
|
US3957789A
|
|
Diaminopropanols
|
|
RO63529A
|
|
Process for the preparation of pyridine derivatives
|
|
IL49786A
|
|
Furo(orthieno)(3,2-c)pyridinium derivatives their preparation and pharmaceutical compositions containing them
|
|
US3914312A
|
|
Process for the preparation of propargylamine
|
|
US3897427A
|
|
2-phenyl-2,3-dihydro-benzo (b) thiophene-1,1-dioxide derivatives
|
|
US3901941A
|
|
New oxyacetic ether derivatives of ortho-thymotic esters
|
|
US3906030A
|
|
New amino ether derivatives of orthothymotic esters
|
